1. Home
  2. ALT vs MFH Comparison

ALT vs MFH Comparison

Compare ALT & MFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • MFH
  • Stock Information
  • Founded
  • ALT 1997
  • MFH 2011
  • Country
  • ALT United States
  • MFH United States
  • Employees
  • ALT N/A
  • MFH N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • MFH Finance: Consumer Services
  • Sector
  • ALT Health Care
  • MFH Finance
  • Exchange
  • ALT Nasdaq
  • MFH Nasdaq
  • Market Cap
  • ALT 397.4M
  • MFH 247.1M
  • IPO Year
  • ALT N/A
  • MFH N/A
  • Fundamental
  • Price
  • ALT $4.19
  • MFH $4.46
  • Analyst Decision
  • ALT Strong Buy
  • MFH
  • Analyst Count
  • ALT 6
  • MFH 0
  • Target Price
  • ALT $18.20
  • MFH N/A
  • AVG Volume (30 Days)
  • ALT 11.7M
  • MFH 394.7K
  • Earning Date
  • ALT 08-07-2025
  • MFH 07-22-2025
  • Dividend Yield
  • ALT N/A
  • MFH N/A
  • EPS Growth
  • ALT N/A
  • MFH N/A
  • EPS
  • ALT N/A
  • MFH N/A
  • Revenue
  • ALT $20,000.00
  • MFH N/A
  • Revenue This Year
  • ALT N/A
  • MFH N/A
  • Revenue Next Year
  • ALT $1,557,547.90
  • MFH N/A
  • P/E Ratio
  • ALT N/A
  • MFH N/A
  • Revenue Growth
  • ALT N/A
  • MFH 125.92
  • 52 Week Low
  • ALT $2.90
  • MFH $1.03
  • 52 Week High
  • ALT $11.16
  • MFH $8.86
  • Technical
  • Relative Strength Index (RSI)
  • ALT 39.67
  • MFH 54.46
  • Support Level
  • ALT $4.33
  • MFH $4.12
  • Resistance Level
  • ALT $4.79
  • MFH $4.41
  • Average True Range (ATR)
  • ALT 0.52
  • MFH 0.37
  • MACD
  • ALT -0.16
  • MFH 0.11
  • Stochastic Oscillator
  • ALT 26.92
  • MFH 88.81

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About MFH Mercurity Fintech Holding Inc.

Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.

Share on Social Networks: